HEXALYSE, lozenge tablet 24 tablets
Active ingredients: Biclotymol, Lysozyme hydrochloride, Enoxolone
Commercialized according to BDPM
Lozenge tablet24 tabletsorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- HEXALYSE, comprimé à sucer
- Pharmaceutical form
- comprimé à sucer
- Route of administration
- orale
- Presentation description
- plaquette(s) PVC PVDC aluminium de 24 comprimé(s)
- Marketing authorisation holder
- BOUCHARA-RECORDATI
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 2 May 2005
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
62794329CIP73638499CIP133400936384996Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| BICLOTYMOLcomprimé | 5 mg · un comprimé | SA |
| CHLORHYDRATE DE LYSOZYMEcomprimé | 5 mg · un comprimé | SA |
| ÉNOXOLONEcomprimé | 5 mg · un comprimé | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.